HBI-2375
Product Specifications
CAS Number
2982574-79-6
Target
Histone Methyltransferase, JAK
Related Pathways
Chromatin/Epigenetic, Angiogenesis, Tyrosine Kinase/Adaptors, Stem Cells, JAK/STAT signaling
Bioactivity
HBI-2375 (HYBI-084) is a selective inhibitor that penetrates the blood-brain barrier and is orally active, targeting the MLL1-WDR5 interaction. It inhibits WDR5 with an IC50 of 4.48 nM and demonstrates antiproliferative activity in MV4;11 leukemia cells with an IC50 of 3.17 μM. Furthermore, HBI-2375 disrupts histone methyltransferase activity in cancer cells and is useful for researching leukemia, glioma, and glioblastoma.
Smiles
N(C(=O)C1=C(Cl)C(C)=C(F)C(N)=C1)C2=C(C=C(F)C(=C2)N3C=C(C(=O)N4CCN(C)CC4)N=N3)N5C[C@@H](C)N(C)[C@@H](C)C5
Molecular Formula
C29H36ClF2N9O2
Molecular Weight
616.11
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1409289-01 100 µg
Mouse Monoclonal human CEACAM-6 (CD66c) Antibody
Sign In for Pricing
View Details orb1409289-02 50 µg
Mouse Monoclonal human CEACAM-6 (CD66c) Antibody
Sign In for Pricing
View Details MBS9437711-01 0.1 mL (Biotin)
EF-2 (Phospho-Thr56) Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9437711-02 0.1 mL (AF350)
EF-2 (Phospho-Thr56) Polyclonal Conjugated Antibody
Sign In for Pricing
View Details MBS9437711-03 0.1 mL (AF405)
EF-2 (Phospho-Thr56) Polyclonal Conjugated Antibody
Sign In for Pricing
View Details